• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quintiles Expands Number of Strategic Site Relationship Managers

Quintiles Expands Number of Strategic Site Relationship Managers

June 29, 2010
CenterWatch Staff

After seeing how a little extra contact with investigative sites improved study-start up times and enrollment, Quintiles has doubled its number of strategic site relationship managers (SSRMs) in the past eight months.

Melissa Holbrook, Quintiles’ senior director of site management, said the SSRM role was created about six years ago in Western Europe and then expanded in the U.S. two years later as part of Quintiles’ efforts to improve communication and relationships with sites. The SSRM’s job entails calling or visiting assigned sites regularly and serving as the main contact when questions or concerns arise.

This is an improvement on what historically had been done. “For most sites, their main contact would be the CRA on individual projects, and they’d have to go up the chain of command on that project to get any answers,” Holbrook remembered.

Sites were frustrated, and on the phone for hours, sometimes never getting their question answered by the CRO.

Now sites–at least those associated with Quintiles’ partner sites program—are a lot happier. At minimum, the SSRM is in touch with the site monthly, and more often the interaction is far more frequent, said Holbrook. Communication is vastly improved, as is planning for future projects. That’s because SSRMs also share, in blinded fashion, information about upcoming studies in Quintiles’ pipeline so the sites can get ready for studies for which they’d be appropriate.

Recently, Holbrook said, it became clear that when an extra person such as a SSRM is staying in close touch with the sites, start-up times improve by about 20% and enrollment jumps 100%. Hiring more SSRMs only made sense.

“We recognized that there’s such a value-add to the relationships we create with sites, that we decided to expand the role and make it more local, decreasing the number of sites that the person is responsible for,” Holbrook said.

Quintiles had about 20 SSRMs worldwide, but has now upped that to 45, and reduced the size and scope of their territories. Each SSRM is currently responsible for on average 15 sites, depending on the region.

No two regions look alike, said Holbrook. For example, Florida, which has many sites, used to constitute one SSRM territory. Now it’s three. Since the expansion, there are 25 territories in the U.S., three in Canada, and the rest are in Western Europe, Poland and India. Holbrook said Quintiles is planning to add new territories in Eastern Europe and the Middle East.

Each SSRM has worked within a site. Holbrook said many of them are former site-based CRCs, site managers, CRAs, clinical team leads or have project management experience. A few are physicians.

“The experience will depend on what is acceptable within the local cultures,” Holbrook said.

By the end of the year, Holbrook said there will likely be 50 to 52 SSRMs total worldwide.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing